109 related articles for article (PubMed ID: 19579083)
1. Effect of somatostatin analogue octreotide in medulloblastoma in xenograft and cell culture study.
Hauser P; Hanzély Z; Máthé D; Szabó E; Barna G; Sebestyén A; Jeney A; Schuler D; Fekete G; Garami M
Pediatr Hematol Oncol; 2009; 26(5):363-74. PubMed ID: 19579083
[TBL] [Abstract][Full Text] [Related]
2. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
[No Abstract] [Full Text] [Related]
3. Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells.
Khoshyomn S; Manske GC; Lew SM; Wald SL; Penar PL
Pediatr Neurosurg; 2000 Sep; 33(3):123-31. PubMed ID: 11096359
[TBL] [Abstract][Full Text] [Related]
4. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
[TBL] [Abstract][Full Text] [Related]
5. PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
Ho WS; Feldman MJ; Maric D; Amable L; Hall MD; Feldman GM; Ray-Chaudhury A; Lizak MJ; Vera JC; Robison RA; Zhuang Z; Heiss JD
Oncotarget; 2016 Mar; 7(11):12447-63. PubMed ID: 26799670
[TBL] [Abstract][Full Text] [Related]
6. The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma.
Jia Y; Lue Y; Swerdloff RS; Lasky JL; Panosyan EH; Dai-Ju J; Wang C
Exp Mol Pathol; 2019 Aug; 109():42-50. PubMed ID: 31085184
[TBL] [Abstract][Full Text] [Related]
7. Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.
Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS
Mol Cancer Ther; 2012 Dec; 11(12):2654-63. PubMed ID: 23012247
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
Zhao B; Zhao H; Zhao N; Zhu XG
J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
[TBL] [Abstract][Full Text] [Related]
9. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
[TBL] [Abstract][Full Text] [Related]
12. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
White L; Sterling-Levis K; Kees UR; Tobias V
J Clin Neurosci; 2001 Mar; 8(2):151-6. PubMed ID: 11484666
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma.
Koizumi M; Onda M; Tanaka N; Seya T; Yamada T; Takahashi Y
Digestion; 2002; 65(4):200-6. PubMed ID: 12239460
[TBL] [Abstract][Full Text] [Related]
15. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
16. Effective and safe tumor inhibition using vinblastine in medulloblastoma.
Nobre L; Pauck D; Golbourn B; Maue M; Bouffet E; Remke M; Ramaswamy V
Pediatr Blood Cancer; 2019 Jun; 66(6):e27694. PubMed ID: 30848061
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.
Mikami T; Uozumi T; Kurisu K; Kawamoto K; Kiya K; Hotta T
Biotherapy; 1994; 8(1):7-17. PubMed ID: 7547084
[TBL] [Abstract][Full Text] [Related]
18. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.
Patil S; Sankpal UT; Hurtado M; Bowman WP; Murray J; Borgmann K; Ghorpade A; Sutphin R; Eslin D; Basha R
Gene; 2019 Jul; 705():67-76. PubMed ID: 30991098
[TBL] [Abstract][Full Text] [Related]
19. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
